Infantile Hemangioma and Updated Recommended Treatment
Autor(a) principal: | |
---|---|
Data de Publicação: | 2019 |
Outros Autores: | , , |
Tipo de documento: | Artigo |
Idioma: | por |
Título da fonte: | Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) |
Texto Completo: | https://doi.org/10.29021/spdv.77.1.1012 |
Resumo: | Infantile hemangioma is a benign vascular tumor that frequently occurs at pediatric age, normally at a rate of 2% to 12% in Caucasian newborn babies, particularly in females. The International Society for The Study of Vascular Anomalies has divided these anomalies into two categories: vascular tumors and vascular malformations, including infantile hemangioma among benign vascular tumors. Clinical evolution is characteristic, and consists of a proliferative phase and a spontaneous involution phase. Diagnosis is usually clinical, but sometimes other diagnostic procedures may eventually be necessary. The majority of infantile hemangioma has a favorable outcome and spontaneous resolution. However, in some cases there are local or systemic complications, with the need for additional therapeutic intervention in case of vital, functional or esthetic risks. Oral propranolol is the current treatment of choice for infantile hemangioma, being the only treatment internationally approved for this indication. It should be started as early as possible to maximize efficacy and avoid potential complications. Other therapeutic options can be considered as a second choice, such as oral, topical or intralesional corticosteroids, topical beta-blockers, pulsed-dye laser or surgery. |
id |
RCAP_050fc6805c54cfd511633a1df1210ebf |
---|---|
oai_identifier_str |
oai:ojs.revista.spdv.com.pt:article/1012 |
network_acronym_str |
RCAP |
network_name_str |
Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) |
repository_id_str |
7160 |
spelling |
Infantile Hemangioma and Updated Recommended TreatmentHemangioma Infantil e Recomendações Terapêuticas AtuaisHemangioma/surgeryHemangioma/therapyLasersPropranololCriançaHemangioma/cirurgiaHemangiomaLasersPropranololInfantile hemangioma is a benign vascular tumor that frequently occurs at pediatric age, normally at a rate of 2% to 12% in Caucasian newborn babies, particularly in females. The International Society for The Study of Vascular Anomalies has divided these anomalies into two categories: vascular tumors and vascular malformations, including infantile hemangioma among benign vascular tumors. Clinical evolution is characteristic, and consists of a proliferative phase and a spontaneous involution phase. Diagnosis is usually clinical, but sometimes other diagnostic procedures may eventually be necessary. The majority of infantile hemangioma has a favorable outcome and spontaneous resolution. However, in some cases there are local or systemic complications, with the need for additional therapeutic intervention in case of vital, functional or esthetic risks. Oral propranolol is the current treatment of choice for infantile hemangioma, being the only treatment internationally approved for this indication. It should be started as early as possible to maximize efficacy and avoid potential complications. Other therapeutic options can be considered as a second choice, such as oral, topical or intralesional corticosteroids, topical beta-blockers, pulsed-dye laser or surgery.O hemangioma infantil é o tumor vascular benigno mais frequente na idade pediátrica, com uma incidência de 2% a 12% em recém-nascidos caucasianos, com predominância no sexo feminino. A International Society for The Study of Vascular Anomalies dividiu as anomalias vasculares em duas categorias: tumores vasculares e malformações vasculares, integrando-se o hemangioma infantil nos tumores vasculares benignos. A evolução clínica é característica, compreendendo uma fase proliferativa e uma fase de involução. O diagnóstico é habitualmente clínico, mas pode haver necessidade de recorrer a métodos auxiliares de diagnóstico. A maioria dos hemangiomas infantis tem evolução favorável no sentido da resolução espontânea, mas nalguns casos pode haver complicações locais ou sistémicas, com necessidade de intervenção terapêutica por situações de risco vital, funcional ou estético. Atualmente, o propranolol oral é o tratamento de escolha para o hemangioma infantil e o único aprovado para esta indicação, devendo ser administrado o mais precocemente possível para uma maior eficácia e um menor número de complicações. Outras opções terapêuticas podem ser equacionadas em segunda linha: corticoides orais, tópicos ou intralesionais, betabloqueantes tópicos, laser ou cirurgia.Sociedade Portuguesa de Dermatologia e Venereologia2019-03-26T00:00:00Zjournal articleinfo:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionapplication/pdfhttps://doi.org/10.29021/spdv.77.1.1012oai:ojs.revista.spdv.com.pt:article/1012Journal of the Portuguese Society of Dermatology and Venereology; Vol 77 No 1 (2019): January / March; 39-46Revista da Sociedade Portuguesa de Dermatologia e Venereologia; v. 77 n. 1 (2019): Janeiro / Março; 39-462182-24092182-2395reponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãoinstacron:RCAAPporhttps://revista.spdv.com.pt/index.php/spdv/article/view/1012https://doi.org/10.29021/spdv.77.1.1012https://revista.spdv.com.pt/index.php/spdv/article/view/1012/617Silva, Maria JoãoPalácios, JorgeRebelo, MónicaTorres, Ericainfo:eu-repo/semantics/openAccess2022-10-06T12:35:10Zoai:ojs.revista.spdv.com.pt:article/1012Portal AgregadorONGhttps://www.rcaap.pt/oai/openaireopendoar:71602024-03-19T16:11:08.996694Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãofalse |
dc.title.none.fl_str_mv |
Infantile Hemangioma and Updated Recommended Treatment Hemangioma Infantil e Recomendações Terapêuticas Atuais |
title |
Infantile Hemangioma and Updated Recommended Treatment |
spellingShingle |
Infantile Hemangioma and Updated Recommended Treatment Silva, Maria João Hemangioma/surgery Hemangioma/therapy Lasers Propranolol Criança Hemangioma/cirurgia Hemangioma Lasers Propranolol |
title_short |
Infantile Hemangioma and Updated Recommended Treatment |
title_full |
Infantile Hemangioma and Updated Recommended Treatment |
title_fullStr |
Infantile Hemangioma and Updated Recommended Treatment |
title_full_unstemmed |
Infantile Hemangioma and Updated Recommended Treatment |
title_sort |
Infantile Hemangioma and Updated Recommended Treatment |
author |
Silva, Maria João |
author_facet |
Silva, Maria João Palácios, Jorge Rebelo, Mónica Torres, Erica |
author_role |
author |
author2 |
Palácios, Jorge Rebelo, Mónica Torres, Erica |
author2_role |
author author author |
dc.contributor.author.fl_str_mv |
Silva, Maria João Palácios, Jorge Rebelo, Mónica Torres, Erica |
dc.subject.por.fl_str_mv |
Hemangioma/surgery Hemangioma/therapy Lasers Propranolol Criança Hemangioma/cirurgia Hemangioma Lasers Propranolol |
topic |
Hemangioma/surgery Hemangioma/therapy Lasers Propranolol Criança Hemangioma/cirurgia Hemangioma Lasers Propranolol |
description |
Infantile hemangioma is a benign vascular tumor that frequently occurs at pediatric age, normally at a rate of 2% to 12% in Caucasian newborn babies, particularly in females. The International Society for The Study of Vascular Anomalies has divided these anomalies into two categories: vascular tumors and vascular malformations, including infantile hemangioma among benign vascular tumors. Clinical evolution is characteristic, and consists of a proliferative phase and a spontaneous involution phase. Diagnosis is usually clinical, but sometimes other diagnostic procedures may eventually be necessary. The majority of infantile hemangioma has a favorable outcome and spontaneous resolution. However, in some cases there are local or systemic complications, with the need for additional therapeutic intervention in case of vital, functional or esthetic risks. Oral propranolol is the current treatment of choice for infantile hemangioma, being the only treatment internationally approved for this indication. It should be started as early as possible to maximize efficacy and avoid potential complications. Other therapeutic options can be considered as a second choice, such as oral, topical or intralesional corticosteroids, topical beta-blockers, pulsed-dye laser or surgery. |
publishDate |
2019 |
dc.date.none.fl_str_mv |
2019-03-26T00:00:00Z |
dc.type.driver.fl_str_mv |
journal article info:eu-repo/semantics/article |
dc.type.status.fl_str_mv |
info:eu-repo/semantics/publishedVersion |
format |
article |
status_str |
publishedVersion |
dc.identifier.uri.fl_str_mv |
https://doi.org/10.29021/spdv.77.1.1012 oai:ojs.revista.spdv.com.pt:article/1012 |
url |
https://doi.org/10.29021/spdv.77.1.1012 |
identifier_str_mv |
oai:ojs.revista.spdv.com.pt:article/1012 |
dc.language.iso.fl_str_mv |
por |
language |
por |
dc.relation.none.fl_str_mv |
https://revista.spdv.com.pt/index.php/spdv/article/view/1012 https://doi.org/10.29021/spdv.77.1.1012 https://revista.spdv.com.pt/index.php/spdv/article/view/1012/617 |
dc.rights.driver.fl_str_mv |
info:eu-repo/semantics/openAccess |
eu_rights_str_mv |
openAccess |
dc.format.none.fl_str_mv |
application/pdf |
dc.publisher.none.fl_str_mv |
Sociedade Portuguesa de Dermatologia e Venereologia |
publisher.none.fl_str_mv |
Sociedade Portuguesa de Dermatologia e Venereologia |
dc.source.none.fl_str_mv |
Journal of the Portuguese Society of Dermatology and Venereology; Vol 77 No 1 (2019): January / March; 39-46 Revista da Sociedade Portuguesa de Dermatologia e Venereologia; v. 77 n. 1 (2019): Janeiro / Março; 39-46 2182-2409 2182-2395 reponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação instacron:RCAAP |
instname_str |
Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação |
instacron_str |
RCAAP |
institution |
RCAAP |
reponame_str |
Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) |
collection |
Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) |
repository.name.fl_str_mv |
Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação |
repository.mail.fl_str_mv |
|
_version_ |
1799130567506132992 |